Position in RDY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,221,196
+$296,775 QoQ
Shares Held
88,173
+33.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $7,470,447 across 34 Drug Manufacturers - Specialty & Generic names. RDY ranks #2 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
27,846 | $3,291,675 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
This page
|
88,173 | $1,221,196 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,056 | $626,186 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
24,651 | $456,536 | |
| 5 | VTRS |
Viatris Inc
|
26,426 | $357,015 | |
| 6 | HLN |
Haleon plc
|
30,272 | $303,022 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
|
96,254 | $263,735 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
1,776 | $233,970 |
All Filings in RDY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,221,196 | 88,173 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $924,421 | 65,842 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,100,226 | 78,700 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,178,953 | 78,440 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $647,167 | 49,065 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,149,354 | 72,790 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,157,745 | 14,572 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $946,432 | 12,422 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $803,329 | 10,952 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $453,244 | 6,514 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $410,381 | 6,137 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $278,567 | 4,414 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $239,618 | 4,209 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $158,613 | 3,065 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $290,539 | 5,551 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $249,033 | 4,496 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $216,120 | 3,878 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $234,429 | 3,584 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $249,746 | 3,834 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $277,647 | 3,777 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $219,592 | 3,577 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $256,929 | 3,604 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $283,317 | 4,073 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $210,767 | 3,976 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $192,414 | 4,771 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||